“Daniel Mack”

As a Name:  Registrant, Group Member and/or Signatory

        

Latest Filing:  3/21/24  as  Registrant

As:  Registrant

        

As:  Group Member  (Co-Filer Non-Registrant:  Partner, Affiliate, etc.)

“Daniel Mack” has been a Group Member with  one  Filer:

        

“Daniel Mack” has/had a Group Member interest in  117  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
3/11/24		CA	Rezolute, Inc.	1	SC 13G	CT	Nantahala Capital Management, LLC
2/14/24			Viemed Healthcare, Inc.	1	SC 13G	CT	Nantahala Capital Management, LLC
2/14/24		MA	RMR Group Inc.	3	SC 13G/A	CT	Nantahala Capital Management, LLC
2/14/24			Theratechnologies Inc.	1	SC 13G	CT	Nantahala Capital Management, LLC
2/14/24		MA	Lyra Therapeutics, Inc.	2	SC 13G/A	CT	Nantahala Capital Management, LLC
2/14/24		CO	Noodles & Co.	1	SC 13G	CT	Nantahala Capital Management, LLC
2/14/24		MN	Neuroone Medical Technologies Corp.	1	SC 13G	CT	Nantahala Capital Management, LLC
2/14/24		CO	Gaia, Inc.	1	SC 13G	CT	Nantahala Capital Management, LLC
2/14/24		CA	Evolus, Inc.	1	SC 13G	CT	Nantahala Capital Management, LLC
2/14/24		IL	Assertio Holdings, Inc.	1	SC 13G	CT	Nantahala Capital Management, LLC
2/14/24			uniQure N.V.	7	SC 13G/A	CT	Nantahala Capital Management, LLC
2/14/24		PA	STRATA Skin Sciences, Inc.	7	SC 13G/A	CT	Nantahala Capital Management, LLC
2/14/24		FL	Red Violet, Inc.	3	SC 13G/A	CT	Nantahala Capital Management, LLC
2/14/24			Luxfer Holdings plc	9	SC 13G/A	CT	Nantahala Capital Management, LLC
2/14/24		CO	Dhi Group, Inc.	6	SC 13G/A	CT	Nantahala Capital Management, LLC
2/14/24		CA	Codexis, Inc.	4	SC 13G/A	CT	Nantahala Capital Management, LLC
2/14/24		NC	Bioventus Inc.	2	SC 13G/A	CT	Nantahala Capital Management, LLC
2/14/24		MA	Spyre Therapeutics, Inc.	8	SC 13G/A	CT	Nantahala Capital Management, LLC
2/14/24			Imax Corp.	3	SC 13G/A	CT	Nantahala Capital Management, LLC
2/14/24		FL	Fortress Biotech, Inc.	4	SC 13G/A	CT	Nantahala Capital Management, LLC
			More...  Please Sign In to list all 117 of them.

“Daniel Mack” has been a Group Member with  3  other Group Members:

As Of	Group Member			Filings       #        Latest		With Filer     (Primary)		Issuer     (Primary)
3/11/24		CT	Wilmot B. Harkey	364	SC 13G	CT	Nantahala Capital Management, LLC	CA	Rezolute, Inc.
7/15/22		•	Nantahala Capital Partners II Ltd. Partnership	8	SC 13D/A	CT	Nantahala Capital Management, LLC	CA	Imageware Systems Inc.
2/13/19		•	Wilmot Harkey	5	SC 13G/A	CT	Nantahala Capital Management, LLC	FL	Emergent Capital, Inc.

As:  Signatory  (Director, Officer, Attorney, Accountant, Banker, Agent, etc.)

“Daniel Mack” has been a Signatory for/with  8  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
3/11/24		CT	Nantahala Capital Management, LLC	169	SC 13G	CA	Rezolute, Inc.
2/2/24		CT	Nantahala Capital Partners Ltd. Partnership	1	SC 13G	CA	Unicycive Therapeutics, Inc.
10/31/23		TX	Aileron Therapeutics, Inc.	1	8-K	—
10/5/23		MA	Capstone Dental Pubco, Inc.	1	S-4/A	—
9/21/23		MD	Elutia Inc.	1	8-K	—
8/31/23		FL	Zevra Therapeutics, Inc.	2	425	FL	Zevra Therapeutics, Inc.
12/19/22		CA	Soleno Therapeutics Inc.	1	8-K	—
12/7/20		TX	Apollo Endosurgery, Inc.	1	8-K	—

“Daniel Mack” has/had a Signatory interest in  80  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
3/11/24		CA	Rezolute, Inc.	1	SC 13G	CT	Nantahala Capital Management, LLC
2/14/24		MA	Lyra Therapeutics, Inc.	2	SC 13G/A	CT	Nantahala Capital Management, LLC
2/14/24		NJ	Cellectar Biosciences, Inc.	1	SC 13G	CT	Nantahala Capital Management, LLC
2/14/24		CA	Unicycive Therapeutics, Inc.	4	SC 13G/A	CT	Nantahala Capital Management, LLC
2/14/24		FL	Zevra Therapeutics, Inc.	2	SC 13G	CT	Nantahala Capital Management, LLC
2/14/24		CA	Soleno Therapeutics Inc.	5	SC 13G/A	CT	Nantahala Capital Management, LLC
2/14/24		TX	RumbleOn, Inc.	3	SC 13G/A	CT	Nantahala Capital Management, LLC
2/14/24		NY	DarioHealth Corp.	4	SC 13G/A	CT	Nantahala Capital Management, LLC
2/14/24			Establishment Labs Holdings Inc.	4	SC 13G/A	CT	Nantahala Capital Management, LLC
1/22/24		CA	Talphera, Inc.	1	SC 13D	CT	Nantahala Capital Management, LLC
6/16/23		CO	Aytu Biopharma, Inc.	2	SC 13D/A	CT	Nantahala Capital Management, LLC
2/14/23		TX	Apollo Endosurgery, Inc.	3	SC 13G/A	CT	Nantahala Capital Management, LLC
2/14/23		MA	RMR Group Inc.	2	SC 13G/A	CT	Nantahala Capital Management, LLC
2/14/23		NY	Falconstor Software Inc.	3	SC 13G/A	CT	Nantahala Capital Management, LLC
2/14/23		PA	STRATA Skin Sciences, Inc.	3	SC 13G/A	CT	Nantahala Capital Management, LLC
2/14/23		NJ	Idw Media Holdings, Inc.	2	SC 13G/A	CT	Nantahala Capital Management, LLC
2/14/23		MI	Alta Equipment Group Inc.	2	SC 13G/A	CT	Nantahala Capital Management, LLC
2/14/23			Autolus Therapeutics plc	2	SC 13G/A	CT	Nantahala Capital Management, LLC
2/14/23			Immatics N.V.	3	SC 13G/A	CT	Nantahala Capital Management, LLC
2/14/23		CA	Shift Technologies, Inc.	2	SC 13G/A	CT	Nantahala Capital Management, LLC
			More...  Please Sign In to list all 80 of them.